SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-264544
Filing Date
2017-08-22
Accepted
2017-08-22 16:01:56
Documents
5
Period of Report
2017-08-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d441726d8k.htm 8-K 22891
2 EX-4.1 d441726dex41.htm EX-4.1 113968
3 EX-10.1 d441726dex101.htm EX-10.1 132637
4 EX-99.1 d441726dex991.htm EX-99.1 8732
5 GRAPHIC g441726g0822132740445.jpg GRAPHIC 3880
  Complete submission text file 0001193125-17-264544.txt   285101
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 171045202
SIC: 2836 Biological Products, (No Diagnostic Substances)